$KALV Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in KalVista Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in KalVista Pharmaceuticals, Inc.. Get notifications about new insider transactions in KalVista Pharmaceuticals, Inc. for free.

Page: < prev 1 2 3 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 22 2019	KALV	KalVista Pharmaceu ...	Palleiko Benjamin L	CBO, CFO and Secret ...	Buy	M	6.74	1,073	7,232	33,573	32.5 K to 33.6 K (+3.30 %)
Apr 18 2019	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Sell	S	25.39	916	23,260	100,034	101 K to 100 K (-0.91 %)
Apr 18 2019	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Sell	S	24.78	3,084	76,406	100,950	104 K to 101 K (-2.96 %)
Apr 10 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	29.40	374	10,994	47,471	47.8 K to 47.5 K (-0.78 %)
Apr 10 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	29.40	13,157	386,753	1,672,105	1.7 M to 1.7 M (-0.78 %)
Apr 10 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	28.53	377	10,756	47,845	48.2 K to 47.8 K (-0.78 %)
Apr 10 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	28.53	13,292	379,227	1,685,262	1.7 M to 1.7 M (-0.78 %)
Apr 10 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	29.49	629	18,550	48,222	48.9 K to 48.2 K (-1.29 %)
Apr 10 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	29.49	22,171	653,865	1,698,554	1.7 M to 1.7 M (-1.29 %)
Apr 09 2019	KALV	KalVista Pharmaceu ...	Maetzel Andreas	Senior Vice Preside ...	Option Exercise	M	7.91	5,000	39,550	60,000
Apr 09 2019	KALV	KalVista Pharmaceu ...	Maetzel Andreas	Senior Vice Preside ...	Sell	S	30.00	5,000	150,011	0	5 K to 0 (-100.00 %)
Apr 09 2019	KALV	KalVista Pharmaceu ...	Maetzel Andreas	Senior Vice Preside ...	Buy	M	7.91	5,000	39,550	5,000	0 to 5 K
Apr 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	28.76	253	7,277	48,851	49.1 K to 48.9 K (-0.52 %)
Apr 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	28.76	8,888	255,653	1,720,725	1.7 M to 1.7 M (-0.51 %)
Apr 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	27.66	1,458	40,326	49,104	50.6 K to 49.1 K (-2.88 %)
Apr 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	27.66	51,373	1,420,885	1,729,613	1.8 M to 1.7 M (-2.88 %)
Apr 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	28.40	969	27,516	50,562	51.5 K to 50.6 K (-1.88 %)
Apr 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	28.40	34,133	969,241	1,780,986	1.8 M to 1.8 M (-1.88 %)
Mar 28 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	27.80	1,012	28,135	51,531	52.5 K to 51.5 K (-1.93 %)
Mar 28 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	27.80	35,653	991,189	1,815,119	1.9 M to 1.8 M (-1.93 %)
Mar 28 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	29.06	1,599	46,466	52,543	54.1 K to 52.5 K (-2.95 %)
Mar 28 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	29.06	56,318	1,636,556	1,850,772	1.9 M to 1.9 M (-2.95 %)
Mar 28 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	29.70	831	24,679	54,142	55 K to 54.1 K (-1.51 %)
Mar 28 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	29.70	29,262	869,008	1,907,090	1.9 M to 1.9 M (-1.51 %)
Mar 20 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	26.70	7,246	193,468	54,973	62.2 K to 55 K (-11.65 %)
Mar 20 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	26.70	255,224	6,814,481	1,936,352	2.2 M to 1.9 M (-11.65 %)
Mar 20 2019	KALV	KalVista Pharmaceu ...	Venrock Healthcare Capital Par ...	10% Owner	Sell	S	28.75	500,000	14,375,000	1,544,112	2 M to 1.5 M (-24.46 %)
Mar 15 2019	KALV	KalVista Pharmaceu ...	Crockett Thomas Andrew	CEO	Sell	S	30.16	3,000	90,484	268,510	271.5 K to 268.5 K (-1.10 %)
Mar 06 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	23.04	893	20,572	62,219	63.1 K to 62.2 K (-1.41 %)
Mar 06 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	23.04	31,439	724,245	2,191,576	2.2 M to 2.2 M (-1.41 %)
Mar 06 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	22.91	1,197	27,420	63,112	64.3 K to 63.1 K (-1.86 %)
Mar 06 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	22.91	42,181	966,240	2,223,015	2.3 M to 2.2 M (-1.86 %)
Feb 21 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.60	4,764	98,138	64,309	69.1 K to 64.3 K (-6.90 %)
Feb 21 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.60	167,779	3,456,247	2,265,196	2.4 M to 2.3 M (-6.90 %)
Feb 21 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.02	641	12,830	69,073	69.7 K to 69.1 K (-0.92 %)
Feb 21 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.02	22,594	452,239	2,432,975	2.5 M to 2.4 M (-0.92 %)
Feb 21 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.73	508	10,532	69,714	70.2 K to 69.7 K (-0.72 %)
Feb 21 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.73	17,912	371,366	2,455,569	2.5 M to 2.5 M (-0.72 %)
Feb 05 2019	KALV	KalVista Pharmaceu ...	Pereira Brian JG	Director	Option Exercise	A	17.95	14,000	251,300	14,000
Jan 29 2019	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Option Exercise	M	0.00	5,453	23	109,455
Jan 29 2019	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Sell	S	17.06	5,453	93,015	82,969	88.4 K to 83 K (-6.17 %)
Jan 29 2019	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Buy	M	0.00	5,453	23	88,422	83 K to 88.4 K (+6.57 %)
Jan 24 2019	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Option Exercise	M	0.00	600	3	114,908
Jan 24 2019	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Option Exercise	M	0.00	1,302	6	115,508
Jan 24 2019	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Sell	S	17.01	600	10,205	82,969	83.6 K to 83 K (-0.72 %)
Jan 24 2019	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Buy	M	0.00	600	3	83,569	83 K to 83.6 K (+0.72 %)
Jan 24 2019	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Sell	S	17.00	1,302	22,139	82,969	84.3 K to 83 K (-1.55 %)
Jan 24 2019	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Buy	M	0.00	1,302	6	84,271	83 K to 84.3 K (+1.57 %)
Jan 18 2019	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Sell	S	19.81	2,300	45,572	104,034	106.3 K to 104 K (-2.16 %)
Jan 18 2019	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Sell	S	19.20	1,700	32,637	106,334	108 K to 106.3 K (-1.57 %)
Jan 16 2019	KALV	KalVista Pharmaceu ...	Crockett Thomas Andrew	CEO	Sell	S	19.86	901	17,896	271,510	272.4 K to 271.5 K (-0.33 %)
Jan 16 2019	KALV	KalVista Pharmaceu ...	Crockett Thomas Andrew	CEO	Sell	S	19.28	9,099	175,432	272,411	281.5 K to 272.4 K (-3.23 %)
Jan 07 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.41	72	1,470	70,222	70.3 K to 70.2 K (-0.10 %)
Jan 07 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.41	2,527	51,581	2,473,481	2.5 M to 2.5 M (-0.10 %)
Jan 07 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.01	47	941	70,294	70.3 K to 70.3 K (-0.07 %)
Jan 07 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.01	1,653	33,081	2,476,008	2.5 M to 2.5 M (-0.07 %)
Jan 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.00	6	120	70,341	70.3 K to 70.3 K (-0.01 %)
Jan 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.00	194	3,880	2,477,661	2.5 M to 2.5 M (-0.01 %)
Jan 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.00	702	14,043	70,347	71 K to 70.3 K (-0.99 %)
Jan 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.00	24,716	494,419	2,477,855	2.5 M to 2.5 M (-0.99 %)
Jan 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.03	103	2,063	71,049	71.2 K to 71 K (-0.14 %)
Jan 02 2019	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.03	3,631	72,718	2,502,571	2.5 M to 2.5 M (-0.14 %)
Dec 21 2018	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.02	59	1,181	71,152	71.2 K to 71.2 K (-0.08 %)
Dec 21 2018	KALV	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Sell	S	20.02	2,077	41,577	2,506,202	2.5 M to 2.5 M (-0.08 %)
Oct 05 2018	KALV	KalVista Pharmaceu ...	Unkart Edward W	Director	Option Exercise	A	22.65	7,000	158,550	7,000
Oct 05 2018	KALV	KalVista Pharmaceu ...	ORONSKY ARNOLD L	Director	Option Exercise	A	22.65	7,000	158,550	7,000
Oct 05 2018	KALV	KalVista Pharmaceu ...	Cha Albert	Director	Option Exercise	A	22.65	7,000	158,550	7,000
Oct 05 2018	KALV	KalVista Pharmaceu ...	ALDRICH RICHARD	Director	Option Exercise	A	22.65	7,000	158,550	7,000
Sep 20 2018	KALV	KalVista Pharmaceu ...	Maetzel Andreas	Senior Vice Preside ...	Option Exercise	A	16.08	20,700	332,856	20,700
Sep 20 2018	KALV	KalVista Pharmaceu ...	Maetzel Andreas	Senior Vice Preside ...	Option Exercise	A	16.08	20,700	332,856	20,700
Sep 20 2018	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Option Exercise	A	16.08	52,600	845,808	52,600
Sep 20 2018	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Option Exercise	A	16.08	52,600	845,808	52,600
Sep 20 2018	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Payment of Exercise	F	17.05	2,500	42,625	108,034	110.5 K to 108 K (-2.26 %)
Sep 20 2018	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Payment of Exercise	F	17.05	2,500	42,625	108,034	110.5 K to 108 K (-2.26 %)
Sep 20 2018	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Grant	A	0.00	12,500	0	110,534	98 K to 110.5 K (+12.75 %)
Sep 20 2018	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Grant	A	0.00	12,500	0	110,534	98 K to 110.5 K (+12.75 %)
Sep 20 2018	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Option Exercise	A	16.08	52,600	845,808	52,600
Sep 20 2018	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Option Exercise	A	16.08	52,600	845,808	52,600
Sep 20 2018	KALV	KalVista Pharmaceu ...	Palleiko Benjamin L	CFO and Secretary	Option Exercise	A	16.08	52,600	845,808	52,600
Sep 20 2018	KALV	KalVista Pharmaceu ...	Palleiko Benjamin L	CFO and Secretary	Option Exercise	A	16.08	52,600	845,808	52,600
Sep 20 2018	KALV	KalVista Pharmaceu ...	Palleiko Benjamin L	CFO and Secretary	Grant	A	0.00	32,500	0	32,500	0 to 32.5 K
Sep 20 2018	KALV	KalVista Pharmaceu ...	Palleiko Benjamin L	CFO and Secretary	Grant	A	0.00	32,500	0	32,500	0 to 32.5 K
Sep 20 2018	KALV	KalVista Pharmaceu ...	Crockett Thomas Andrew	CEO	Option Exercise	A	16.08	150,000	2,412,000	150,000
Sep 20 2018	KALV	KalVista Pharmaceu ...	Crockett Thomas Andrew	CEO	Option Exercise	A	16.08	150,000	2,412,000	150,000
Sep 12 2018	KALV	KalVista Pharmaceu ...	ORONSKY ARNOLD L	Director	Buy	P	17.00	58,824	1,000,008	388,766	329.9 K to 388.8 K (+17.83 %)
Sep 12 2018	KALV	KalVista Pharmaceu ...	Cha Albert	Director	Buy	P	17.00	1,058,824	18,000,008	1,359,149	300.3 K to 1.4 M (+352.56 %)
Jun 06 2018	KALV	KalVista Pharmaceu ...	Maetzel Andreas	Senior Vice Preside ...	Option Exercise	A	8.21	20,700	169,947	20,700
Jun 06 2018	KALV	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Option Exercise	A	8.21	51,800	425,278	51,800
Jun 06 2018	KALV	KalVista Pharmaceu ...	Palleiko Benjamin L	CFO and Secretary	Option Exercise	A	8.21	71,700	588,657	71,700
Jun 06 2018	KALV	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Option Exercise	A	8.21	53,500	439,235	53,500
Jun 06 2018	KALV	KalVista Pharmaceu ...	Crockett Thomas Andrew	CEO	Option Exercise	A	8.21	130,800	1,073,868	130,800
Oct 19 2017	KALV	KalVista Pharmaceu ...	ALDRICH RICHARD	Director	Buy	P	8.61	565,065	4,866,961	934,484	369.4 K to 934.5 K (+152.96 %)
Oct 16 2017	KALV	KalVista Pharmaceu ...	RA CAPITAL MANAGEMENT, LLC	Director	Buy	P	8.50	850,000	7,225,000	1,441,070	591.1 K to 1.4 M (+143.81 %)
Oct 16 2017	KALV	KalVista Pharmaceu ...	Shah Rajeev M.	Director	Buy	P	8.50	850,000	7,225,000	1,441,070	591.1 K to 1.4 M (+143.81 %)
Oct 12 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	8.50	1,726,000	14,671,000	0	1.7 M to 0 (-100.00 %)
Oct 12 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	10.02	481	4,820	1,726,000	1.7 M to 1.7 M (-0.03 %)
Oct 12 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	10.21	35,519	362,763	1,726,481	1.8 M to 1.7 M (-2.02 %)
Oct 12 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	15.36	75,123	1,153,889	1,762,000	1.8 M to 1.8 M (-4.09 %)
Oct 12 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	14.07	57,580	809,961	1,837,123	1.9 M to 1.8 M (-3.04 %)
Oct 12 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	13.39	61,044	817,330	1,894,703	2 M to 1.9 M (-3.12 %)
Oct 12 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	12.32	165,199	2,036,012	1,955,747	2.1 M to 2 M (-7.79 %)
Oct 12 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	11.18	190,981	2,134,404	2,120,946	2.3 M to 2.1 M (-8.26 %)
Oct 12 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	10.36	413,356	4,281,004	2,311,927	2.7 M to 2.3 M (-15.17 %)
Sep 29 2017	KALV	KalVista Pharmaceu ...	Resnick Joshua	Director	Option Exercise	A	6.71	6,000	40,260	6,000
Sep 29 2017	KALV	KalVista Pharmaceu ...	Unkart Edward W	Director	Option Exercise	A	6.71	6,000	40,260	6,000
Sep 29 2017	KALV	KalVista Pharmaceu ...	Shah Rajeev M.	Director	Option Exercise	A	6.71	6,000	40,260	6,000
Sep 29 2017	KALV	KalVista Pharmaceu ...	ORONSKY ARNOLD L	Director	Option Exercise	A	6.71	6,000	40,260	6,000
Sep 29 2017	KALV	KalVista Pharmaceu ...	Cha Albert	Director	Option Exercise	A	6.71	6,000	40,260	6,000
Sep 29 2017	KALV	KalVista Pharmaceu ...	ALDRICH RICHARD	Director	Option Exercise	A	6.71	6,000	40,260	6,000
Sep 29 2017	KALV	KalVista Pharmaceu ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	A	6.71	6,000	40,260	6,000
Sep 15 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	8.00	3	24	2,725,280	2.7 M to 2.7 M (0.00 %)
Sep 15 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	7.00	140,744	985,841	2,725,283	2.9 M to 2.7 M (-4.91 %)
Sep 15 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	8.05	10,000	80,500	2,866,027	2.9 M to 2.9 M (-0.35 %)
Sep 15 2017	KALV	KalVista Pharmaceu ...	Novo Holdings A/S	10% Owner	Sell	S	8.02	25,900	207,614	2,876,027	2.9 M to 2.9 M (-0.89 %)
May 26 2017	CBYL	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Option Exercise	A	7.07	33,800	238,966	33,800
May 26 2017	CBYL	KalVista Pharmaceu ...	Palleiko Benjamin L	CFO and Secretary	Option Exercise	A	7.07	33,800	238,966	33,800
May 26 2017	CBYL	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Option Exercise	A	7.07	33,800	238,966	33,800
May 26 2017	CBYL	KalVista Pharmaceu ...	Crockett Thomas Andrew	CEO	Option Exercise	A	7.07	187,000	1,322,090	187,000
Mar 27 2017	CBYL	KalVista Pharmaceu ...	Unkart Edward W	Director	Option Exercise	A	7.88	12,000	94,560	12,000
Mar 27 2017	CBYL	KalVista Pharmaceu ...	Shah Rajeev M.	Director	Option Exercise	A	7.88	12,000	94,560	12,000
Mar 27 2017	CBYL	KalVista Pharmaceu ...	Resnick Joshua	Director	Option Exercise	A	7.88	12,000	94,560	12,000
Mar 27 2017	CBYL	KalVista Pharmaceu ...	ORONSKY ARNOLD L	Director	Option Exercise	A	7.88	12,000	94,560	12,000
Mar 27 2017	CBYL	KalVista Pharmaceu ...	Cha Albert	Director	Option Exercise	A	7.88	12,000	94,560	12,000
Mar 27 2017	CBYL	KalVista Pharmaceu ...	ALDRICH RICHARD	Director	Option Exercise	A	7.88	12,000	94,560	12,000
Mar 27 2017	CBYL	KalVista Pharmaceu ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	A	7.88	12,000	94,560	12,000
Mar 09 2017	CBYL	KalVista Pharmaceu ...	Maetzel Andreas	Senior Vice Preside ...	Option Exercise	A	7.91	65,000	514,150	65,000
Dec 30 2016	CBYL	KalVista Pharmaceu ...	Palleiko Benjamin L	CFO and Secretary	Option Exercise	A	6.74	60,684	409,010	60,684
Nov 30 2016	CBYL	KalVista Pharmaceu ...	Feener Edward P.	Chief Scientific Of ...	Option Exercise	A	10.21	20,055	204,762	20,055
Nov 29 2016	CBYL	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Option Exercise	A	0.01	116,810	1,635	116,810
Nov 29 2016	CBYL	KalVista Pharmaceu ...	Yea Christopher	Chief Development O ...	Grant	A	0.00	82,969	0	82,969	0 to 83 K
Nov 29 2016	CBYL	KalVista Pharmaceu ...	Resnick Joshua	Director	Grant	A	0.00	71,211	0	71,211	0 to 71.2 K
Nov 29 2016	CBYL	KalVista Pharmaceu ...	Resnick Joshua	Director	Grant	A	0.00	2,508,279	0	2,508,279	0 to 2.5 M
Nov 29 2016	CBYL	KalVista Pharmaceu ...	ALDRICH RICHARD	Director	Grant	A	0.00	369,419	0	369,419	0 to 369.4 K
Nov 28 2016	CBYL	KalVista Pharmaceu ...	Palleiko Benjamin L	CFO and Secretary	Option Exercise	A	8.39	49,354	414,080	49,354
Nov 28 2016	CBYL	KalVista Pharmaceu ...	Crockett Thomas Andrew	President and CEO	Grant	A	0.00	281,420	0	281,420	0 to 281.4 K
Nov 25 2016	CBYL	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Grant	A	0.00	71,211	0	71,211	0 to 71.2 K
Nov 25 2016	CBYL	KalVista Pharmaceu ...	SVLSF IV, LLC	10% Owner	Grant	A	0.00	2,508,279	0	2,508,279	0 to 2.5 M
Nov 23 2016	CBYL	KalVista Pharmaceu ...	RA CAPITAL MANAGEMENT, LLC	Director	Grant	A	0.00	591,070	0	591,070	0 to 591.1 K
Nov 23 2016	CBYL	KalVista Pharmaceu ...	Shah Rajeev M.	Director	Grant	A	0.00	591,070	0	591,070	0 to 591.1 K
Nov 23 2016	CBYL	KalVista Pharmaceu ...	Renzi David	President & CEO	Option Exercise	M	7.84	36,640	287,258	0
Nov 23 2016	CBYL	KalVista Pharmaceu ...	Renzi David	President & CEO	Sell	U	8.59	3,186	27,378	0	3.2 K to 0 (-100.00 %)
Nov 23 2016	CBYL	KalVista Pharmaceu ...	Renzi David	President & CEO	Payment of Exercise	F	8.59	33,454	287,477	3,186	36.6 K to 3.2 K (-91.30 %)
Nov 23 2016	CBYL	KalVista Pharmaceu ...	Renzi David	President & CEO	Buy	M	7.84	36,640	287,258	36,640	0 to 36.6 K
Nov 22 2016	CBYL	KalVista Pharmaceu ...	Basta Steven L	Director	Option Exercise	M	7.84	1,125	8,820	0
Nov 22 2016	CBYL	KalVista Pharmaceu ...	Basta Steven L	Director	Sell	U	8.59	99	851	0	99 to 0 (-100.00 %)
Nov 22 2016	CBYL	KalVista Pharmaceu ...	Basta Steven L	Director	Payment of Exercise	F	8.59	1,026	8,817	99	1.1 K to 99 (-91.20 %)
Nov 22 2016	CBYL	KalVista Pharmaceu ...	Basta Steven L	Director	Buy	M	7.84	1,125	8,820	1,125	0 to 1.1 K
Nov 22 2016	CBYL	KalVista Pharmaceu ...	Maroney Marcee	VP, Clinical Affair ...	Option Exercise	M	7.84	732	5,739	0
Nov 22 2016	CBYL	KalVista Pharmaceu ...	Maroney Marcee	VP, Clinical Affair ...	Option Exercise	M	7.84	1,339	10,498	0
Nov 22 2016	CBYL	KalVista Pharmaceu ...	Maroney Marcee	VP, Clinical Affair ...	Option Exercise	M	7.84	2,592	20,321	0

Page: < prev 1 2 3 next >